Wall Street Zen Upgrades Cabot (NYSE:CBT) to “Buy”

Cabot (NYSE:CBT) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Sunday.

Other equities analysts have also recently issued research reports about the company. JPMorgan Chase & Co. boosted their price objective on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday. UBS Group reduced their price target on Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research report on Wednesday, August 5th. Mizuho boosted their price target on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. Truist Financial set a $100.00 price target on Cabot in a report on Wednesday, August 5th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $89.00.

Cabot Stock Performance

Shares of NYSE CBT opened at $86.38 on Friday. The company has a 50 day simple moving average of $87.91 and a two-hundred day simple moving average of $80.05. The stock has a market cap of $4.46 billion, a price-to-earnings ratio of 24.33, a PEG ratio of 11.45 and a beta of 0.84. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. Cabot has a 12 month low of $58.33 and a 12 month high of $94.53.

Cabot (NYSE:CBT) last issued its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.66 by $0.01. The firm had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm’s revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, analysts predict that Cabot will post 6.32 earnings per share for the current year.

Institutional Trading of Cabot

Institutional investors have recently modified their holdings of the stock. NewEdge Advisors LLC raised its position in shares of Cabot by 2,559.5% during the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after purchasing an additional 947 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after buying an additional 108,645 shares during the last quarter. Empowered Funds LLC boosted its holdings in Cabot by 102.6% in the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock worth $2,341,000 after buying an additional 14,260 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Cabot by 3.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock worth $10,145,000 after buying an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. increased its stake in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.